UTILISATION DE L'INTERLEUKINE-22 DANS LE TRAITEMENT DE LA STÉATOSE HÉPATIQUE
- 专利权人:
- GENERON (SHANGHAI) CORP.
- 发明人:
- 申请号:
- EP08797018.2
- 公开号:
- EP2185202B1
- 申请日:
- 2008.08.01
- 申请国别(地区):
- EP
- 年份:
- 2015
- 代理人:
- 摘要:
- The present invention relates to use of interleukin-22 (IL-22) for treating fatty liver disease by decreasing the levels of transaminases. The use of IL-22 in decreasing the levels of transaminases is also provided.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- UTILISATION DE L'INTERLEUKINE-22 DANS LE TRAITEMENT DE LA STÉATOSE HÉPATIQUE
- UTILISATION DE L'INTERLEUKINE-22 DANS LE TRAITEMENT DE LA STEATOSE HEPATIQUE
- USE OF INTERLEUKIN-22 IN THE TREATMENT OF FATTY LIVER DISEASE
- Use of interleukin-22 in the treatment of fatty liver disease
- USE OF INTERLEUKIN-22 IN THE TREATMENT OF FATTY LIVER DISEASE